Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.49 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.49 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.47 |
| ▸ | CYP4F11 | Q9HBI6 | 1/20 | 0.47 |
| ▸ | CYP4F12 | Q9HCS2 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1205512 | 0.96 | CYP4F2 (0.52) | ALOX5NPC1PPARAPPARGCYP4F2 | |
| SCHEMBL901475 | 0.91 | CYP4F2 (0.55) | ALOX5NPC1PPARAPPARGCYP4F2 | |
| SCHEMBL765924 | 0.85 | ALOX5 (0.57) | ALOX5NPC1PPARAPPARGCYP4F2 | |
| SCHEMBL19089791 | 0.85 | ALOX5 (0.57) | ALOX5PPARAPPARGCYP4F2CYP4A11 | |
| SCHEMBL10110850 | 0.84 | ALOX5 (0.49) | ALOX5NPC1PPARAPPARGCYP4F2 | |
| SCHEMBL20195256 | 0.84 | NPC1 (0.45) | ALOX5NPC1PPARAPPARGCYP4F2 | |
| SCHEMBL3906464 | 0.84 | ALOX5 (0.56) | ALOX5PPARAPPARGCYP4F2CYP4A11 | |
| SCHEMBL11066194 | 0.83 | NPC1 (0.46) | ALOX5NPC1PPARAPPARGCYP4F2 | |
| SCHEMBL19899012 | 0.82 | ALOX5 (0.54) | ALOX5PPARAPPARGCYP4F2CYP4A11 | |
| SCHEMBL11588395 | 0.82 | ALOX5 (0.54) | ALOX5PPARAPPARGCYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9365494-B2 | Process for synthesis of amino-methyl tetralin derivatives | ROCHE PALO ALTO LLC (US) | 2016-06-14 | — | — | US | disclosed |
| US-9365494-B2 | Process for synthesis of amino-methyl tetralin derivatives | ROCHE PALO ALTO LLC (US) | 2016-06-14 | — | — | US | disclosed |
| US-9365494-B2 | Process for synthesis of amino-methyl tetralin derivatives | ROCHE PALO ALTO LLC (US) | 2016-06-14 | — | — | US | disclosed |
| CN-102245562-B | Process for the synthesis of amino-methyltetralin derivatives | HOFFMANN LA ROCHE | 2014-08-13 | — | — | CN | disclosed |
| EP-2379491-B1 | Process for synthesis of amino-methyl tetraline derivatives | HOFFMANN LA ROCHE (CH) | 2013-03-20 | — | — | EP | disclosed |
| EP-2379491-B1 | Process for synthesis of amino-methyl tetraline derivatives | HOFFMANN LA ROCHE (CH) | 2013-03-20 | — | — | EP | disclosed |
| US-20120323040-A1 | PROCESS FOR SYNTHESIS OF AMINO-METHYL TETRALIN DERIVATIVES | DURKIN KIERAN (US) | 2012-12-20 | — | — | US | disclosed |
| US-20120323040-A1 | PROCESS FOR SYNTHESIS OF AMINO-METHYL TETRALIN DERIVATIVES | DURKIN KIERAN (US) | 2012-12-20 | — | — | US | disclosed |
| US-20120323040-A1 | PROCESS FOR SYNTHESIS OF AMINO-METHYL TETRALIN DERIVATIVES | DURKIN KIERAN (US) | 2012-12-20 | — | — | US | disclosed |
| US-8119842-B2 | Process for synthesis of amino-methyl tetralin derivatives | Roche Palo Alto LLP (US) | 2012-02-21 | — | — | US | disclosed |
| US-8119842-B2 | Process for synthesis of amino-methyl tetralin derivatives | Roche Palo Alto LLP (US) | 2012-02-21 | — | — | US | disclosed |
| US-8119842-B2 | Process for synthesis of amino-methyl tetralin derivatives | Roche Palo Alto LLP (US) | 2012-02-21 | — | — | US | disclosed |
| CN-102245562-A | Process for the synthesis of amino-methyltetralin derivatives | HOFFMANN LA ROCHE | 2011-11-16 | — | — | CN | disclosed |
| EP-2379491-A1 | PROCESS FOR SYNTHESIS OF AMINO-METHYL TETRALINE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2011-10-26 | — | — | EP | disclosed |
| WO-2010069778-A1 | PROCESS FOR SYNTHESIS OF AMINO-METHYL TETRALINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2010-06-24 | — | — | WO | disclosed |
| WO-2010069778-A1 | PROCESS FOR SYNTHESIS OF AMINO-METHYL TETRALINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2010-06-24 | — | — | WO | disclosed |
| US-20100160682-A1 | PROCESS FOR SYNTHESIS OF AMINO-METHYL TETRALIN DERIVATIVES | ROCHE PALO ALTO LLC | 2010-06-24 | — | — | US | disclosed |
| US-20100160682-A1 | PROCESS FOR SYNTHESIS OF AMINO-METHYL TETRALIN DERIVATIVES | ROCHE PALO ALTO LLC | 2010-06-24 | — | — | US | disclosed |
| US-20100160682-A1 | PROCESS FOR SYNTHESIS OF AMINO-METHYL TETRALIN DERIVATIVES | ROCHE PALO ALTO LLC | 2010-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160682-A1 | PROCESS FOR SYNTHESIS OF AMINO-METHYL TETRALIN DERIVATIVES | PKN2, CCND2, PRMT1 | ALOX5 2651/4885NPC1 3667/4885PPARA 3453/4885 |
| US-20120323040-A1 | PROCESS FOR SYNTHESIS OF AMINO-METHYL TETRALIN DERIVATIVES | PKN2, CCND2, PRMT1 | ALOX5 2828/4885NPC1 3692/4885PPARA 3503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.